TITLE

Efficacious, effective, and embedded interventions: implementation research in infectious disease control

AUTHOR(S)
Allotey, Pascale; Reidpath, Daniel D.; Ghalib, Hashim; Pagnoni, Franco; Skelly, William C.
PUB. DATE
January 2008
SOURCE
BMC Public Health;2008, Vol. 8, p343
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Research in infectious disease control is heavily skewed towards high end technology; development of new drugs, vaccines and clinical interventions. Oft ignored, is the evidence to inform the best strategies that ensure the embedding of interventions into health systems and amongst populations. In this paper we undertake an analysis of the challenge in the development of research for the sustainable implementation of disease control interventions. Results: We highlight the fundamental differences between the research paradigms associated with the development of technologies and interventions for disease control on the one hand and the research paradigms required for enhancing the sustainable uptake of those very same interventions within the communities on the other. We provide a definition for implementation research in an attempt to underscore its critical role and explore the multidisciplinary science needed to address the challenges in disease control. Conclusion: The greatest value for money in health research lies in the sustainable and effective implementation of already proven, efficacious solutions. The development of implementation research that can help provide some solutions on how this can be achieved is sorely needed
ACCESSION #
51485994

 

Related Articles

  • The Vaccine. Dawood, Richard; Hack, Susan // Conde Nast Traveler;Nov2005, Vol. 40 Issue 11, p88 

    Discusses medical developments related to the use of vaccines in preventing diseases. History on the use smallpox vaccines; Description of the diseases that can be prevented through immunization; Recommendations for further research on more effective vaccines.

  • Does neonatal BCG vaccination protect against tuberculous meningitis? Walker, V.; Selby, G.; Wacogne, I. // Archives of Disease in Childhood;Sep2006, Vol. 91 Issue 9, p789 

    The article investigates the potential value of neonatal BCG vaccination in protecting children against tuberculosis meningitis by researchers from Birmingham, England. A review of previous studies indicate widely ranging suggestions. A meta-analysis performed in 1993 sought to differentiate...

  • Declining Hepatitis A Mortality in the United States during the Era of Hepatitis A Vaccination. Vogt, Tara M.; Wise, Matthew E.; Bell, Beth P.; Finelli, Lyn // Journal of Infectious Diseases;5/1/2008, Vol. 197 Issue 9, p1282 

    Background. Since the mid-1990s, hepatitis A vaccine has been recommended for US children living in historically high-incidence states and for persons with other risk factors or chronic liver disease (CLD). The incidence of hepatitis A has declined dramatically during the era of vaccination, but...

  • WEST NILE A Vaccine on the Way ... But Not This Summer. Carmichael, Mary // Newsweek;6/7/2004, Vol. 143 Issue 23, p14 

    Offers a look at the development of a vaccine for the West Nile virus. Discussion of the long-term effects of the disease including shortness of breath, fevers, pain, paralysis and irreversible nerve damage; Report on a clinical trial of a vaccine by Acambis.

  • Adverse Events Reported Following Live, Cold-Adapted, Intranasal Influenza Vaccine. Izurieta, Hector S.; Haber, Penina; Wise, Robert P.; Iskander, John; Pratt, Douglas; Mink, ChrisAnna; Chang, Soju; Braun, M. Miles; Ball, Robert // JAMA: Journal of the American Medical Association;12/7/2005, Vol. 294 Issue 21, p2720 

    Context: In June 2003, the US Food and Drug Administration licensed a trivalent live, attenuated influenza vaccine (LAIV-T) for intranasal administration to healthy persons 5 to 49 years of age. Although prelicensure testing involved 20 228 vaccinees, clinical trials were not of sufficient size...

  • Modeling Human Papillomavirus Vaccine Effectiveness: Quantifying the Impact of Parameter Uncertainty. Nicolas Van de Velde; Marc Brisson; Marie-Claude Boily // American Journal of Epidemiology;Apr2007, Vol. 165 Issue 7, p762 

    The development of models is based on assumptions, which inevitably embed a level of uncertainty. Quantifying such uncertainty is particularly important when modeling human papillomavirus (HPV) vaccine effectiveness; the natural history of infection and disease is complex, and age- and...

  • VETAID begins vaccination campaign in Somaliland.  // Veterinary Record: Journal of the British Veterinary Association;6/14/2008, Vol. 162 Issue 24, p767 

    The article reports that the Scottish-based international development organization VETAID has begun a mass vaccination campaign in western Somaliland. It mentions that VETAID estimates between 55 to 66 percent of livestock in the area were lost and more than 2000 families have become destitute....

  • Updated Recommendations on the Use of Pneumococcal Conjugate Vaccine: Suspension of Recommendation for Third and Fourth Dose.  // MMWR: Morbidity & Mortality Weekly Report;3/5/2004, Vol. 53 Issue 8, p177 

    Presents recommendations on the use of pneumococcal conjugate vaccine (PCV7) for infants in the U.S. Causes of scarcity of the vaccine; Efficacy of the product; Details of the recommendations.

  • Vaccination Week of the Americas, April 24--30, 2004.  // MMWR: Morbidity & Mortality Weekly Report;4/16/2004, Vol. 53 Issue 14, p310 

    Announces that the countries in the Americas will participate in the Vaccination Week of the Americas (VWA) from April 24 to 30, 2004. Goals of the VWA; Target group for vaccination; Number of people who will be given vaccines.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics